Yves Dory
Professeur associé, Faculté des sciences
FSCI Département de chimie
Présentation
Diplômes
- (1985-1988). Ph.D. Chemistry. University of Southampton. Southampton, Southampton, Royaume-Uni.
- (1982-1984). M.Sc. Chemistry. Université de Rennes 1. Rennes, France.
Expériences académiques
- Full Professor. (2005-). Université de Sherbrooke Faculté des Sciences. Sherbrooke, QC, Canada.
- Associate Professor. (1997-2005). Université de Sherbrooke Faculté des Sciences. Sherbrooke, QC, Canada.
- Assistant Professor. (1993-1997). Université de Sherbrooke Faculté des Sciences. Sherbrooke, QC, Canada.
- Group Leader. (1991-1993). Endorecherche.inc. Québec, QC, Canada.
- PDF. (1989-1990). Université de Sherbrooke Faculté des Sciences. Sherbrooke, QC, Canada.
Publications
Articles
- Sadaf Ghanaatgar Kasbi, Martin Savard, Céléna Dubuc, Yves Dory, Brigitte Guérin, Fernand Gobeil. (2025). Preclinical Theranostic Profiling of [64Cu]Cu-Acetate in Prostate Cancer. Molecules. DOI
- Sadaf Ghanaatgar Kasbi, Martin Savard, Frédéric Couture, Céléna Dubuc, Véronique Dumulon-Perreault, Marie-Edith Nepveu-Traversy, Samia Ait-Mohand, Robert Sabbagh, Sameh Geha, Brigitte Guérin, Yves Dory, Fernand Gobeil. (2025). Theranostic Potential of a New <sup>64</sup>Cu-Labeled NOTA-R954 Peptide Conjugate for Kinin B1R Expressing Prostate Cancer. Pharmaceutics. DOI
- Bin Li, Glenn P. A. Yap, Vincent St-Onge, Niki Mavragani, Thi Thanh Hà Dao, Pierre Baillargeon, Patrick Fournier, Yves L. Dory, Jerome P. Claverie. (2024). Monoatomic Nickel Wires via Columnar Self-Assembly of Tribenzocyclyne Nickel Complexes. ACS Materials Letters. DOI
- Pauline Navals, Anna Kwiatkowska, Nawel Mekdad, Frédéric Couture, Roxane Desjardins, Robert Day, Yves L. Dory. (2023). Enhancing the Drug-Like Profile of a Potent Peptide PACE4 Inhibitor by the Formation of a Host–Guest Inclusion Complex with β-Cyclodextrin. Molecular Pharmaceutics. DOI
- Maxime Gagnon, Martin Savard, Thi Minh Hue Tran, Laurence Vincent, Alexandre Moquin, Philippe Tremblay, Xavier Roucou, Yves Dory, Fernand Gobeil. (2023). Evaluation of Novel B1R/B2R Agonists Containing TRIOZAN™ Nanoparticles for Targeted Brain Delivery of Antibodies in a Mouse Model of Alzheimer Disease. Molecules. DOI
- Tárcius N. Ramos, Laura Le Bras, Yves L. Dory, Benoît Champagne. (2023). Cover Feature: Second Harmonic Generation Signatures of Supramolecular Assemblies Based on Amide Moieties (ChemPhysChem 13/2023). ChemPhysChem. DOI
- Tárcius N. Ramos, Laura Le Bras, Yves L. Dory, Benoît Champagne. (2023). Second Harmonic Generation Signatures of Supramolecular Assemblies Based on Amide Moieties. ChemPhysChem. DOI
- Niousha Nazari, Sylvain Bernard, Daniel Fortin, Thomas Marmin, Louis Gendron, Yves L. Dory. (2023). Triple Thorpe–Ingold Effect in the Synthesis of 18‐Membered C3 Symmetric Lactams Stacking as Endless Supramolecular Tubes. Chemistry – A European Journal. DOI
- Monika A. Lewandowska-Goch, Anna Kwiatkowska, Teresa Łepek, Kévin Ly, Pauline Navals, Hugo Gagnon, Yves L. Dory, Adam Prahl, Robert Day. (2021). Design and Structure–Activity Relationship of a Potent Furin Inhibitor Derived from Influenza Hemagglutinin. ACS Medicinal Chemistry Letters. DOI
- Aiman H. Alnahwi, Samia Ait-Mohand, Véronique Dumulon-Perreault, Yves L. Dory, Brigitte Guérin. (2020). Promising Performance of 4HMS, a New Zirconium-89 Octadendate Chelator. ACS Omega. DOI
- Yves L. Dory, Mia Caron, Vincent Olivier Duguay, Lucas Chicoine-Ouellet, Daniel Fortin, Pierre Baillargeon. (2019). Preparation and Single Crystal Structure Determination of the First Biobased Furan-Polydiacetylene Using Topochemical Polymerization. Crystals. DOI
- Thomas Marmin, Yves L. Dory. (2019). Self‐Assembly of C3 Symmetric Rigid Macrolactams into Very Polar and Porous Trigonal Crystals. Chemistry – A European Journal. DOI
- Jean-Louis Beaudeau, Véronique Blais, Brian J. Holleran, Alexandre Bergeron, Graciela Piñeyro, Brigitte Guérin, Louis Gendron, Yves L. Dory. (2019). N-Guanidyl and C-Tetrazole Leu-Enkephalin Derivatives: Efficient Mu and Delta Opioid Receptor Agonists with Improved Pharmacological Properties. ACS Chemical Neuroscience. DOI
- Anna Kwiatkowska, Frédéric Couture, Samia Ait-Mohand, Roxane Desjardins, Yves L. Dory, Brigitte Guérin, Robert Day. (2019). Enhanced anti-tumor activity of the Multi-Leu peptide PACE4 inhibitor transformed into an albumin-bound tumor-targeting prodrug. Scientific Reports. DOI
- Vahid Dianati, Pauline Navals, Frédéric Couture, Roxane Desjardins, Anthony Dame, Anna Kwiatkowska, Robert Day, Yves L. Dory. (2018). Improving the Selectivity of PACE4 Inhibitors through Modifications of the P1 Residue. Journal of Medicinal Chemistry. DOI
- Vahid Dianati, Anna Kwiatkowska, Frédéric Couture, Roxane Desjardins, Yves L. Dory, Robert Day. (2018). Increasing C-Terminal Hydrophobicity Improves the Cell Permeability and Antiproliferative Activity of PACE4 Inhibitors against Prostate Cancer Cell Lines. Journal of Medicinal Chemistry. DOI
- Vahid Dianati, Azar Shamloo, Anna Kwiatkowska, Roxane Desjardins, Armand Soldera, Robert Day, Yves L. Dory. (2017). Rational Design of a Highly Potent and Selective Peptide Inhibitor of PACE4 by Salt Bridge Interaction with D160 at Position P3. ChemMedChem. DOI
- (2016). Isomorphous Crystals from Diynes and Bromodiynes Involved in Hydrogen and Halogen Bonds. Crystals. DOI
Autres contributions
Cours enseignés ou supervisés à l'UdeS
- CHM010 - Introduction à la chimie générale. (2024-2026). (3CR).
- BCM400 - Chimie pharmaceutique. (2024-2025). (3CR).
- BCM518 - Chimie médicinale. (2024-2025). (2CR).
Divers
- Laura Le Bras, Yves L. Dory, Benoît CHAMPAGNE. (2021). Computational Prediction of the Supramolecular Self-Assembling Properties of Organic Molecules: Flexibility vs Rigidity.
